February 3, 2026

Quicklime demand strengthens across core industrial sectors

Quicklime is a highly reactive calcium compound used across industries to treat water, extract minerals, and manufacture chemicals...

Central bank policy divergence to shape FX markets in 2026

In 2026, diverging rate policies and macro trends are shaping currency markets, investors will need to act selectively across FX pairs...

Metals pull back sharply after speculative surge

TEAM reduced gold and silver exposure ahead of the recent correction, and still sees long‑term value in the sector...

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 64.80% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has emerged as a notable player in the biotechnology industry, capturing investor interest with an impressive potential upside of 64.80%. Headquartered in Radnor, Pennsylvania, this..

Viridian Therapeutics (VRDN) Stock Analysis: Exploring a Promising 26% Upside with Strong Buy Ratings

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company dedicated to the development of treatments for serious and rare diseases, is capturing the attention of investors with its robust growth potential..

AdaptHealth Corp. (AHCO) Stock Analysis: A 32% Upside Awaits Investors in the Home Medical Equipment Sector

AdaptHealth Corp. (NASDAQ: AHCO) is strategically positioned in the healthcare sector, specifically within the medical devices industry. Specializing in the distribution of home medical equipment (HME) and services, AdaptHealth serves..

Artivion, Inc. (AORT) Investor Outlook: Potential Upside of 25.43% and Strong Buy Ratings

Artivion, Inc. (NYSE: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a noteworthy potential upside of 25.43%. This Georgia-based..

Harrow, Inc. (HROW) Stock Analysis: Strong Buy Ratings and a 57% Potential Upside

Harrow, Inc. (NASDAQ: HROW), a growing player in the healthcare sector, is making waves in the pharmaceutical industry, particularly in the realm of ophthalmic solutions. With a market capitalization of..

Amphastar Pharmaceuticals (AMPH): Investor Outlook with 13% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as an intriguing prospect within the healthcare sector, particularly in the niche of specialty and generic drug manufacturing. With a market capitalization of $1.3..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 40% Potential Upside in Non-Opioid Pain Management Solutions

Investors eyeing opportunities in the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) a compelling option, given its focus on non-opioid pain management and regenerative health solutions. With a..

agilon health, inc. (AGL) Stock Analysis: Navigating a 19% Potential Upside Amidst Challenges

For investors with a keen eye on the healthcare sector, agilon health, inc. (NYSE: AGL) presents a complex but intriguing opportunity. Despite some concerning metrics in its financials, the company..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a Potential 54.91% Upside in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the healthcare sector, particularly within the biotechnology industry, is capturing investor attention with its robust growth prospects and strategic partnerships. Headquartered in..

Structure Therapeutics Inc. (GPCR): Analyst Ratings Suggest Nearly 20% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a key player in the biotechnology sector, has captured investor attention with its innovative approach to addressing chronic diseases. With a market capitalization of $6.35..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 116% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves within the healthcare industry. The company, based in Hampton, New Jersey, is dedicated to the..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 48% Potential Upside Amidst Market Challenges

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is recognized for its innovative approach to vaccine development. With a market capitalization of $1.41 billion, Novavax operates from..

Wave Life Sciences Ltd. (WVE): Analyst Consensus Highlights 143.73% Potential Upside for Biotech Innovator

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine development. The Singapore-based clinical-stage company is gaining investor attention, particularly..

Edgewise Therapeutics (EWTX): Analyst Consensus Reveals a 32% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a dynamic presence in the biotechnology sector, is drawing significant attention in the investment community. Specializing in the development of therapies for muscle disorders, this..

Integra LifeSciences Holdings C (IART) Stock Analysis: A 38.89% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Princeton, New Jersey, Integra LifeSciences has carved..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 226.80% Upside

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a prominent player in the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with its potential upside of 226.80%. This North Carolina-based..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Market Volatility and Growth Challenges

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. The company, headquartered in Pleasanton, California, has carved a niche..

Search

Funds

February 3, 2026

Quicklime demand strengthens across core industrial sectors

Quicklime is a highly reactive calcium compound used across industries to treat water, extract minerals, and manufacture chemicals...

Central bank policy divergence to shape FX markets in 2026

In 2026, diverging rate policies and macro trends are shaping currency markets, investors will need to act selectively across FX pairs...

Metals pull back sharply after speculative surge

TEAM reduced gold and silver exposure ahead of the recent correction, and still sees long‑term value in the sector...
Search

Funds

February 3, 2026

FTSE 100

Funds